Literature DB >> 22692283

Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.

Samson W Fine1.   

Abstract

Beyond the typical acinar morphology observed in the majority of prostatic adenocarcinomas, a spectrum of morphologic variants and prostate cancer subtypes exists. These unusual entities may be classified as: (1) cancer morphologies arising by divergent differentiation of prostatic ductal, acinar, or basal cells and associated with unique clinical features and/or therapeutic approaches, and (2) histologies occurring in the context of usual prostatic adenocarcinoma that may result in diagnostic misinterpretation or difficulties in Gleason grade assignment, especially in limited samples. This article details a number of variants, with emphasis on diagnostic criteria, differential diagnoses, and clinical significance.

Entities:  

Mesh:

Year:  2012        PMID: 22692283     DOI: 10.1097/PAP.0b013e31825c6b92

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  7 in total

1.  Collagenous micronodules in prostate cancer revisited: are they solely associated with Gleason pattern 3 adenocarcinomas?

Authors:  Mi J Kim; Mukul K Divatia; Jeong H Lee; Steven Shen; Brian J Miles; Jun H Hwang; Alberto G Ayala; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

2.  De novo large cell neuroendocrine carcinoma of the prostate, case report and literature review.

Authors:  Gabriel Acosta-Gonzalez; Jia Qin; Rosemary Wieczorek; Jonathan Melamed; Fang-Ming Deng; Ming Zhou; Danil Makarov; Fei Ye; Zhiheng Pei; Matthew R Pincus; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2014-12-25

3.  Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.

Authors:  Steven C Weindorf; Alexander S Taylor; Chandan Kumar-Sinha; Dan Robinson; Yi-Mi Wu; Xuhong Cao; Daniel E Spratt; Michelle M Kim; Amir Lagstein; Arul M Chinnaiyan; Rohit Mehra
Journal:  Med Oncol       Date:  2019-02-02       Impact factor: 3.064

4.  Solitary Spinal Epidural Metastasis from Prostatic Small Cell Carcinoma.

Authors:  Kyung Ryeol Lee; Young Hee Maeng
Journal:  Case Rep Radiol       Date:  2016-06-16

5.  TGFβ signaling limits lineage plasticity in prostate cancer.

Authors:  Yi Hao; Glen A Bjerke; Karolina Pietrzak; Tiffany A Melhuish; Yu Han; Stephen D Turner; Henry F Frierson; David Wotton
Journal:  PLoS Genet       Date:  2018-05-21       Impact factor: 5.917

6.  Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.

Authors:  Glen A Bjerke; Karolina Pietrzak; Tiffany A Melhuish; Henry F Frierson; Bryce M Paschal; David Wotton
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

7.  Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells.

Authors:  Oh-Joon Kwon; Li Zhang; Deyong Jia; Li Xin
Journal:  Oncogene       Date:  2020-10-27       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.